Sight is one of the five senses that give us knowledge and perception of the world around us. And a condition that hinders our sight can be devastating. Stem cell therapy can rejuvenate and even reverse some eye conditions.Learn More
Stem Cell Therapy and Your Eyes
Stem cell science has focused on developing protocols to mitigate the loss of vision that occurs in ophthalmologic conditions including Retinitis Pigmentosa, Macular Degeneration, Optic Neuritis, and Glaucoma. The properties of mesenchymal stem cells such as plasticity, neuroprotection, and immunomodulation possess many advantages to addressing ophthalmologic diseases.
Age-related macular degeneration (AMD) is the most common retinal degenerative disease in the elderly. This devastating disease affects the macula, which is the part of the retina that allows people to read, visualize faces, and drive. Treatment options include antioxidant vitamins and laser therapy; however, stem cells offer great potential for addressing AMD.
Retinitis pigmentosa (RP) encompasses a group of inherited conditions that cause progressive retinal degeneration resulting in vision loss, especially at night. Current treatment options include vitamin and nutritional supplementation and experimental therapies including gene therapy, retinal cell transplantation, and retinal prosthesis. Stem cells offer a minimally invasive investigational alternative.
Optic Neuritis involves inflammatory, demyelination of the optic nerve, which may result in vision loss, eye pain, photopsias (flickering or flashing light), and/or loss of color vision. Standard treatment uses corticosteroids to reduce inflammation. Stem cell therapy addresses the cause of optic neuritis instead of solely reducing inflammation.
Glaucoma is characterized by elevated intraocular pressure, which leads to optic nerve damage, progressive visual field loss and ultimately, irreversible blindness if left untreated. Current therapies include prescription drugs, laser therapy, and surgery. Stem cells offer the hope of mitigating the loss of vision.
Stevens-Johnson syndrome (SJS)
Stevens-Johnson syndrome (SJS) is a form of toxic epidermal necrolysis (TEN), which is a life-threatening skin condition where cell death causes the skin layers of the epidermis to separate from the dermis. This syndrome is considered to be a hypersensitivity complex that affects the skin and mucous membranes, and can be caused by certain medications, infections or more rarely cancers. SJS can affect the ocular components resulting in conjunctival infection, sloughing of skin, erythematous macules and patches, and symblepharon formation may occur with severe pseudomembranous conjunctivitis. Primary corneal and iritis involvement are rare. Later complications may occur to include structural anomalies of the eyelid, (ectropion and entropion) and Trichiasis. Damage to tear and oil glands can develop and lead to dry eyes with lack of tear production necessary for the health of the ocular surface.
Call (888) 453-6825 to schedule an appointment!
We Made History!
Together, Dr. Ahvie Herskowitz and Dr. David Milstein made history performing the first SJS (Stevens-Johnson Syndrome) stem cell subconjunctival injections on 7-9-15 at the San Francisco Stem Cell Treatment Center! In this video, Dr. Herskowitz talks about SJS and how stem cells can play a part in reversing it.
If you have questions about a bill or other information, then please call us directly at 1 (888) 453-6825.
Any and all statements and opinions are provided for educational information and are not intended for medical diagnosis. As with all medical treatments and procedures, results may vary on an individual basis.
We are closed on Federal Holidays.
Where we are
Anatara Medicine & San Francisco Stem Cell Treatment Center | 1700 California Street, Suite 520 | San Francisco, CA 94109 | P: 1 (888) 453-6825 | F: (415) 345-0059